BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 2981174)

  • 1. Lack of correlation between loss of anchorage-independent growth and levels of transformation-specific p53 protein in retinoic acid-treated F9 embryonal carcinoma cells.
    Rodrigues M; Balicki D; Newrock KM; Mukherjee BB
    Exp Cell Res; 1985 Jan; 156(1):22-30. PubMed ID: 2981174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-transcriptional control of myc and p53 expression during differentiation of the embryonal carcinoma cell line F9.
    Dony C; Kessel M; Gruss P
    Nature; 1985 Oct 17-23; 317(6038):636-9. PubMed ID: 2414665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinoic acid-induced transition from protein kinase C beta to protein kinase C alpha in differentiated F9 cells: correlation with altered regulation of proto-oncogene expression by phorbol esters.
    Khuri FR; Cho Y; Talmage DA
    Cell Growth Differ; 1996 May; 7(5):595-602. PubMed ID: 8732669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new differentiated cell line (Dif 5) derived by retinoic acid treatment of F9 teratocarcinoma cells capable of extracellular matrix production and growth in the absence of serum.
    Nagarajan L; Jetten AM; Anderson WB
    Exp Cell Res; 1983 Sep; 147(2):315-27. PubMed ID: 6193979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of F9 embryonal carcinoma cell differentiation by inhibition of polyamine synthesis.
    Oredsson SM; Billgren M; Heby O
    Eur J Cell Biol; 1985 Sep; 38(2):335-43. PubMed ID: 3930245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of a parathyroid hormone-like protein and its receptor during differentiation of embryonal carcinoma cells.
    Chan SD; Strewler GJ; King KL; Nissenson RA
    Mol Endocrinol; 1990 Apr; 4(4):638-46. PubMed ID: 2177844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Commitment to differentiation induced by retinoic acid in P19 embryonal carcinoma cells is cell cycle dependent.
    Mummery CL; van den Brink CE; de Laat SW
    Dev Biol; 1987 May; 121(1):10-9. PubMed ID: 2883052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of fibroblast growth factor by F9 teratocarcinoma cells as a function of differentiation.
    Braunhut SJ; Gudas LJ; Kurokawa T; Sasse J; D'Amore PA
    J Cell Biol; 1989 Jun; 108(6):2467-76. PubMed ID: 2544608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth and differentiation of embryonal carcinoma cell line F9 in defined media.
    Rizzino A; Crowley C
    Proc Natl Acad Sci U S A; 1980 Jan; 77(1):457-61. PubMed ID: 6244561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular analysis of early growth-associated events during the differentiation of F9 cells into embryoid bodies.
    Whitman MM; Shen YM; Soprano D; Soprano KJ
    Cancer Res; 1990 Jun; 50(11):3193-8. PubMed ID: 2139801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Butyrate inhibits the retinoic acid-induced differentiation of F9 teratocarcinoma stem cells.
    Levine RA; Campisi J; Wang SY; Gudas LJ
    Dev Biol; 1984 Oct; 105(2):443-50. PubMed ID: 6090244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of c-jun, but not retinoic acid receptor beta, is associated with F9 teratocarcinoma stem cell differentiation induced by polyamine depletion.
    Bjersing JL; Brorsson A; Heby O
    J Cell Biochem; 1997 Dec; 67(3):378-85. PubMed ID: 9361192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restoration of anchorage regulation in transformed cells by retinoic acid (RA) is independent of the presence of cytoplasmic RA-binding proteins.
    Mukherjee BB; Mobry PM; Lacroix A; Bhat PV
    Exp Cell Res; 1983 Aug; 147(1):63-74. PubMed ID: 6311597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conditions affecting the differentiation of F9 teratocarcinoma cells: potentiation of response by cyclic AMP.
    Grover A; Adamson ED
    In Vitro Cell Dev Biol; 1986 May; 22(5):280-4. PubMed ID: 2423499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Embryonal carcinoma cells differentiate into parietal endoderm via an intermediate stage corresponding to primitive endoderm.
    Damjanov I; Zhu ZM; Andrews PW; Fenderson BA
    In Vivo; 1994; 8(6):967-73. PubMed ID: 7772748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of extracellular matrices on F9 teratocarcinoma stem cells: a crucial role of type IV collagen in the early stage of differentiation of F9 stem cells.
    Watanabe K; Toda S; Yonemitsu N; Sugihara H
    Pathobiology; 2002-2003; 70(4):219-28. PubMed ID: 12679600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of immunoreactive calcitonin and parathyroid hormone by embryonal carcinoma cells: alteration with retinoic acid-induced differentiation.
    Evain-Brion D; Binet E; Donnadieu M; Laurent P; Anderson WB
    Dev Biol; 1984 Aug; 104(2):406-12. PubMed ID: 6745491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of alpha 6/beta 1 integrin expression during differentiation of F9 murine embryonal carcinoma cells to parietal endoderm.
    Morini M; Piccini D; Barbieri O; Astigiano S
    Exp Cell Res; 1997 May; 232(2):304-12. PubMed ID: 9168806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct functions of protein kinase Calpha and protein kinase Cbeta during retinoic acid-induced differentiation of F9 cells.
    Cho Y; Klein MG; Talmage DA
    Cell Growth Differ; 1998 Feb; 9(2):147-54. PubMed ID: 9486851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative switch in integrin expression accompanies differentiation of F9 cells treated with retinoic acid.
    Burdsal CA; Lotz MM; Miller J; McClay DR
    Dev Dyn; 1994 Dec; 201(4):344-53. PubMed ID: 7894073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.